News | February 24, 2021
Aurobindo Pharma to acquire 26% ownerships solar power companies
The company will be holding 26% of the share capital in each of the solar power generating companies.
The company will be holding 26% of the share capital in each of the solar power generating companies.
The company will review FDA's response and decide on appropriate next steps soon.
Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.
DHL and other logistics companies were already transporting pharmaceutical products at minus 70°C in Schaumaplast boxes packed with dry ice before the coronavirus pandemic
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness
Dr. Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 2pt February 2021.
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
India business grew 11.8% YoY vs mid-single digit industry growth.
The jump in profit is due to the better performance of the API business.
Subscribe To Our Newsletter & Stay Updated
